HCA Healthcare, Inc. $HCA Shares Acquired by BI Asset Management Fondsmaeglerselskab A S

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

BI Asset Management Fondsmaeglerselskab A S grew its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 21.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 117,677 shares of the company's stock after buying an additional 20,934 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S's holdings in HCA Healthcare were worth $40,663,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also modified their holdings of the company. Cheviot Value Management LLC acquired a new position in HCA Healthcare during the 1st quarter worth $26,000. Atwood & Palmer Inc. acquired a new position in HCA Healthcare during the 1st quarter worth $28,000. Bartlett & CO. Wealth Management LLC grew its stake in HCA Healthcare by 888.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after purchasing an additional 80 shares in the last quarter. ORG Partners LLC grew its stake in HCA Healthcare by 344.0% during the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after purchasing an additional 86 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. grew its stake in HCA Healthcare by 75.8% during the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock worth $40,000 after purchasing an additional 50 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

HCA has been the subject of a number of recent analyst reports. Barclays decreased their price target on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a report on Monday, July 28th. Robert W. Baird lifted their price target on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a report on Thursday, August 14th. Wolfe Research downgraded HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. Morgan Stanley reduced their target price on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a report on Monday, July 28th. Finally, Royal Bank Of Canada reduced their target price on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a report on Monday, July 28th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have assigned a Hold rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $398.58.

HCA Healthcare Stock Performance

HCA traded up $0.61 on Friday, hitting $404.87. 1,081,188 shares of the company traded hands, compared to its average volume of 1,431,386. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. The company has a 50 day moving average of $373.91 and a 200-day moving average of $353.90. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The stock has a market capitalization of $94.74 billion, a PE ratio of 17.02, a PEG ratio of 1.27 and a beta of 1.39.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. During the same quarter in the previous year, the firm posted $5.50 EPS. The firm's quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is currently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.